Epicardio

Epicardio is a MedEd/MedTech company founded in 2011 with a vision to revolutionize medical education and technology. The company's flagship product, Epicardio Simulation™, is a cloud-based real-time 3D electromechanical simulation designed to aid in understanding the complexities of the heart. With a client base including prestigious medical schools such as Oxford, Cambridge, and Karolinska, as well as partnerships with industry giants like Schiller, Medtronic, Boston Scientific, and Abbott, Epicardio has made significant strides in the medical training and diagnostics support sector.

Epicardio's goal of becoming a global leader in simulation-based medical eTraining and eDiagnosis support signifies its ambition to improve accessibility, reduce costs, and minimize patient risk in the healthcare industry. The company is dedicated to developing a world-class range of intelligent simulation software targeted at multiple international markets. Epicardio's commitment to creating an outstanding working environment reflects its drive for excellence and innovation.

Though specific details about the last investment and investors are not available, Epicardio's pioneering approach to medical education and technology positions it as an intriguing prospect for potential investors and collaborators. For opportunities with Epicardio, interested parties can reach out via email at contact (at) epicardio (dot) com.